Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.

A new study led by York University, looking at the health data of nearly 15,000 people enrolled in a medically supervised ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

The Royal College of GPs’ weight loss expert has sounded a warning bell for users of popular drugs Ozempic, Mounjaro and ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

President Donald Trump's executive order directs pharmaceutical companies to lower their prices to levels closer to those ...

Ozempic is a prescription drug used to deal with conditions related to high blood sugar levels and for diabetes management.

GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...

Medications such as Wegovy, Mounjaro and Ozempic were found to have disease-prevention qualities beyond their weight-loss ...

TWO blockbuster weight loss just have been tested against each other for the first time in a head-to-head trial. There was a clear winner, which saw slimmers shed 20 per cent of their body weight.

If you're considering taking a GLP-1 medication, and you also have a digestive condition, you may be wondering about side ...